Patient Review and Coordination Program

Similar documents
WA PMP Access by Public Payers. PDMP North Regional Meeting St. Louis, MO April 23-24

A nation in pain: Focus on Medicaid

Curbing Prescription Drug Abuse in Medicaid

Opiate Use among Ohio Medicaid Recipients

Follow-up to Previous Reviews

Medicaid Perspective

Idaho DUR Board Meeting Minutes

Prescription Drug Abuse National Perspective

PACIFICSOURCE COMMUNITY SOLUTIONS AND GORGE COORDINATED CARE ORGANIZATION. Chronic Pain and Opiate Management Initiatives

North Carolina, like the rest of the nation, has been experiencing

Notice from the Executive Officer: Promoting Compliance with the Existing Limited Use Criteria for Fentanyl Transdermal Patch

Prescription Opioid Overdose in Oregon: A public health perspective

Oregon s PDMP: An epidemiological assist tool

Medicare Advantage Outreach and Education Bulletin

Idaho DUR Board Meeting Minutes

MEDICAL ASSISTANCE BULLETIN

Managed Care Pushes for Safer Opioid Oversight

Idaho DUR Board Meeting Minutes

Blue Cross of Idaho Addresses State s Opioid Issue

Interior AIDS Association

Medical vs. Use of Drugs. Warning Signs of Chemical Dependence. Intent Effect. Legality Pattern 5/5/2010. Daily use above ceiling doses

ADAPTING YOUR COURT STRUCTURE

MANAGING PAIN WHILE MINIMIZING RISK OF SUBSTANCE USE DISORDER OUTLINE. EPIDEMIC / CRISIS The Epidemic / Crisis Around Opioid Prescription Use

Franklin GF: WA Opioid Guidelines November 7, E WA COHE / St. Luke's Spokane 1

Ranked in the top 10% in: -Low percent of adults reporting fair or poor health

Opioids drive continued increase in drug overdose deaths

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

Idaho DUR Board Meeting Minutes

CDC s Approach to Addressing the Opioid Overdose Epidemic

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

FOLLOW DIRECTIONS. How to Use Methadone Safely. U.S. Department of Health & Human Services

Mental Illness and Addiction:

NJPMP & Safer Prescribing

COUNTY OF SAN DIEGO. Opioid Update

Drugs in the Workforce: The Rise of Prescription Opioid Use and Abuse. Don Teater MD

Idaho DUR Board Meeting Minutes. Committee Member Present: David Agler, M.D., Dawn Berheim, Pharm.D., Perry Brown, M.D., Matthew Hyde, Pharm.D.

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

Na#onal Ins#tute for Health Care Management Founda#on Webinar

Medicare Advantage Outreach and Education Bulletin

High-Decile Prescribers: All Gain, No Pain?

See Important Reminder at the end of this policy for important regulatory and legal information.

Agenda. CWCI: Background

Meth and Opioid Abuse Prevention Efforts

The Prescription Drug Overdose Epidemic

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

Brief History of Methadone Maintenance Treatment

Introducing ValueOptions Clinical Care Alerts

Kentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018

Idaho DUR Board Meeting Minutes. Committee Member Present: Matthew Hyde, Pharm.D., Perry Brown M.D., Paul Cady, Pharm.D., Ryan Heyborne M.D.

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country

DAWN. In 2009, nearly 4.6 million emergency

In 2009, nearly 4.6 million emergency

Applying Population Health Management to Opiate Prescription Medication Misuse

Greenbrier County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Opioid Task Force Kick-Off Meeting. February 29, 2016

OHIO LEGISLATIVE SERVICE COMMISSION

Prescription for Disaster: Impact of Drugs in our Society

CLINICAL POLICY Clinical Policy: Extended Release Opioid Analgesics

solutions MEDICATION MIS MANAGEMENT and Chronic Pain 10/4/2016 Opioid Abuse: Current Data Opioid Abuse: Current Data

Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction

The Impact of Opioid Use and Abuse on Medical Community, Businesses, Social Organizations and Individiuals and Their Families

Connecticut Medical Assistance Pharmacy Program Drug Utilization Review (DUR) Program DUR Board Meeting

News & Views. Antipsychotics on Maryland Medicaid PDL and Coverage of a 30-day Emergency Supply of Atypical Antipsychotics

TennCare s Opioid Strategy

SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP)

The Population is Abusing Drugs, but are Drugs Abusing Insurance?

Medicaid and the Opioid Crisis

Limitations of use: Subsys may be dispensed only to patients enrolled in the TIRF REMS Access program (1).

DEPARTMENT OF VETERANS AFFAIRS SUMMARY: The Department of Veterans Affairs (VA) proposes to amend its medical

Michael M. Miller, MD, FASAM, FAPA

Kentucky All Schedule Prescription Electronic Reporting (KASPER)

Veteran s Integrative Pain (VIP) Center: A program for high risk patients on chronic opioids

Protocol For: Personally Furnishing Naloxone. Update Log

PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health

Managing Narcotics on Workers Comp Claims. Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc.

Idaho DUR Board Meeting Minutes

How to Conduct an Effective Medication Therapy Management Session in the Community Pharmacy

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response.

Medicare Part D Opioid Policies for 2019 Information for Patients

An Integrated Healthcare System s Approach to Chronic Pain

Clinical Policy: Opioid Analgesics Reference Number: CP.PMN.97 Effective Date: Last Review Date: 02.19

DEPARTMENT OF VETERANS AFFAIRS SUMMARY: The Department of Veterans Affairs (VA) is amending its medical

Policy Evaluation: Substance Use Disorders

Issue Brief Prescription Drug Misuse in Vermont

Subject: Pain Management (Page 1 of 7)

Statewide Substance Abuse Services

Clinical Policy: Opioid Analgesics Reference Number: CP.PMN.97 Effective Date: Last Review Date: 02.18

Innovative Ways to Fund Harm Reduction Services New Mexico

Prescription Drug Abuse: Developing Evidence-Based State Level Interventions

Health TALK. Toothache? Did you know?

Opioid Addiction Statistics

Clinical Policy: Opioid Analgesics Reference Number: OH.PHAR.PPA.13 Effective Date: 10/2017 Last Review Date: 6/2018 Line of Business: Medicaid

CHSP, CPSO RN, BSN, JD,

Evaluation of a Medicaid Psychotropic Drug Management Program in Utah

Suboxone, Zubsolv, Bunavail (buprenorphine with naloxone sublingual tablets and film), Buprenorphine sublingual tablets

Mark W. Caverly, Chief Liaison and Policy Section

Barbour County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report Barbour County

Stark County Safety Council Presentation: Opioid & Anti-Anxiety Medication Use Among Ohio s Injured Workers

Transcription:

Patient Review and Coordination Program For Medical Assistance Clients Who Need Assistance In Appropriate Use of Phyllis Coolen, RN, MN Division of Healthcare Health and Recovery Administration January 2009 1

Key Issues National and statewide data indicate an increase in number of deaths due to opiates Medicaid-specific population Increase use of prescription opiates Clients with minor medical diagnoses and high risk medical conditions receive large amounts of narcotics Emergency room (ER) cycling correlates with narcotics Narcotics are easily obtained through the ER Complex issues requires more than one solution and the need for partnerships Social and Health 2

Key Findings on Opiates and ER Utilization Aged, blind, or disabled medical assistance clients who are frequent ER visitors: Have high rates of mental illness and alcohol/drug disorders frequently co-occurring Receive large volumes of prescription opiates Relatively few receive drug/alcohol treatment services Many receive mental health services 3

Average Number of Pain Prescriptions is Highest Among Those Most Frequently Visiting the ER Pain Rx Among Frequent ER Users 29.1 Narcotic Analgesic Prescriptions Per Client in FY 2006 20.1 15.3 10.6 1.9 3.7 5.1 6.8 No Visits One Two 3 to 5 6 to 10 11 to 20 21 to 30 31+ n = 96,433 n = 24,435 n = 10,987 n = 10,966 n = 4,134 n = 1,554 n = 314 n = 224 Number of Visits to the ER, FY 2006 INCLUDES persons who are Medicaid-only aged, blind, disabled, presumptively disabled, or General Assistance-Unemployable in FY 2006. 4 SOURCE = DSHS RDA Client Outcome Database. TOTAL CLIENTS (FY 2006) = 149,050.

Patient Review and Coordination (PRC) Program Washington State s health and safety program for Medicaid fee-for-service, managed care, and state-funded clients who overuse or inappropriately use medical services AUTHORITY Federal requirement of all Medicaid programs 42CFR 431.54 (e); 456.3; 455.1-16 Washington Administrative Code 388-501-0135 Website: http://apps.leg.wa.gov/wac/default.aspx?cite=388-501- 0135 5

Objectives of the PRC Program Decrease and control over-utilization and inappropriate use of health care Minimize medically unnecessary and addictive drug use Provide patient education and coordination of care Help providers manage clients with education and resource referrals; facilitate coordination of care Reduce expenditures on unnecessary and inappropriate services 6

Identification of Clients for PRC Review Clients identified for review: Direct Referrals internal & external Majority of external referrals are from pharmacies PRC Website Algorithms run monthly High narcotic users High number of prescribers for narcotics High emergency room users with non-emergent diagnosis 7

Criteria for PRC Review and Placement (Must be Medically Necessary) Any two in a ninety day period: from 4 or more different providers Prescriptions filled by 4 or more different pharmacies 10 or more prescriptions Prescriptions written by 4 or more different prescribers Received similar services from 2 or more providers in same day 10 or more office visits 8

Criteria for PRC Review and Placement Any one within a ninety day period: 2 or more emergency room visits Medical history of at risk behavior Repeated and documented efforts to seek services that were not medically necessary Counseled at least once by a health care provider or the department about the appropriate use of healthcare services Received controlled substances from two different prescribers in one month History of duplicative, excessive, or contraindicated health care services Received healthcare services that are not within acceptable medical practice 9

Criteria for PRC Review and Placement At Risk would include: Forging of altering prescriptions Paying cash for controlled substances Unauthorized use of client s medical assistance identification care Frequent seeking of services that is not medically necessary 10

PRC Review Outcome Placement into PRC with initial restriction for 24 months Client is restricted to certain providers: Primary Care Provider Pharmacy Narcotic Prescriber Hospital for non-emergent care System edits that denies claims from unassigned providers PRC restriction takes precedence over all edits in the Pharmacy (Point of Sale) POS system 11

Top 10 Diagnosis for Top 200 PRC Clients May 2008 HEADACHE/MIGRAINE ABDOMINAL PAIN LUMBAGO/BACK PAIN, SPRAIN OR STRAIN CHEST PAIN PAIN, SPRAIN OR STRAIN IN LIMB CERVICALGIA/NECK PAIN, SPRAIN OR STRAIN DENTAL DISORDER NOS OTHER CHRONIC PAIN DEPRESSIVE DISORDER NEC ANXIETY STATE NOS 0 200 400 600 800 1000 1200 Number of Claims 12

Morphine Equivalent Dose (MED) Schedule Medication Detailed Report Fro 4/7/2008 To 9/18/2008 RECIPIENT: XXX DOS DRUG STRGTH QTY DS SCHED PHARM DATE PRES PRESCRIBER 4/7/08 Morphine 100 mg 1500 30 H3A A 4/20/08 Smith, MD 4/7/08 Triazolam 0.25mg 60 30 H2E B 4/20/08 Smith, MD 4/7/08 Oxycodone 30 mg 950 20 H3A C 4/20/08 Smith, MD 4/7/08 Diazepam 10 mg 120 30 H2F D 4/20/08 Smith, MD Total DS 110 Total MED: 192,750mg/30days = 6,425mg MED per day 13

14

PRC Program Effectiveness Expanded Program in 2005 Additional FTEs, plus significant process improvement activities = data base systems, automated processes Current caseload = > 3,060 (200 cases in CY05) Current FTEs: 3 clinical nurse advisors 7 program managers (daily care management) 2 support staff 15

PRC Savings and Utilization Outcomes Savings since FY 2006 = > $43.9 Million Savings >$1.5 Million/month 33% decrease in emergency room visits 37% decrease in physician visits 24% decrease in number of prescriptions 16

PRC Clients who completed their 2 year restriction in 2007 and 2008 (N=1364) 50% were released for compliance 28% retained, usually continued high ER use 15% no longer eligible for medical assistance 6% are currently in review 17

PRC Clients referred for Narcotic Abuse in 2006 (N=518) Average # of narcotics prescriptions went from 3.07 to 1.63 Average number of prescribers went from 4.8 to 2.8 Total Morphine Equivalent Dosage (MED) decreased to185 MED/day from 312 MED/day Total narcotic claims went from 2274 to 839 total claims 18

PRC Managed Care Program Managed Care Clients January 08 7 Managed Care Plans Restriction to provider types is managed care plan specific Clients are restricted to a plan for 12 months Utilization and Cost Savings 1 st 4 months Plan A = 42 Patients 31% reduction in overall costs ($1366 to $948 PM/PM) (direct and indirect monthly costs) Plan B = 158 Patients Pharmacy Savings = $4,338.00 ER Utilization Savings = $42,884.00 19

Washington Medicaid Deaths Related to Prescription Opioids 2004-2006 The Pacific states (WA., OR., CALIF., HI., AK.) ranked the highest in life use and for nonmedical use of pain relievers. (SAMHSA s 2005-2006 Report) In 2006, the leading cause of unintentional injury death in Washington was poisoning: Over 90% of poisoning were due to drug overdoses Deaths have continued to rise from 24 deaths in 1995 to 638 deaths in 2006 20

Washington Medicaid Deaths Related to Prescription Opioids 2004-2006 Almost 50% of Washington State s death due to prescription opioids were Medicaid clients WA Medicaid CY2004 555 180 CY2005 569 272 CY2006 638 296 60% died at home Highest age group for both male and female was between 40-59 years of age (65%) 15 children (15-19 years of age) died 21

Top 25 Medical Diagnosis The Year Prior to Death Diagnosis and Count of Clients *LUMBAGO/BACK PAIN, SPRAIN OR STRAIN (159) *PAIN, SPRAIN OR STRAIN IN LIMB (194) *ABDOMINAL PAIN (118) *HEADACHE/MIGRAINE (77) *CHEST PAIN (115) SUBSTANCE ABUSE PROGRAM (31) DRUG DEPEND NOS-UNSPEC (38) CHR AIRWAY OBSTRUCT NEC (53) *CERVICALGIA/NECK PAIN, SPRAIN OR STRAIN (82) SHORTNESS OF BREATH (72) CELLULITIS OF LEG (36) PNEUMONIA, ORGANISM NOS (49) HUMAN IMMUNO VIRUS (HIV) DISEASE (14) DIABETES W/O COMPLICATION (55) ALCOH DEP NEC/NOS-UNSPEC (16) ASTHMA, UNSPECIFIED (35) OTHER CONVULSIONS (35) MYALGIA AND MYOSITIS NOS (51) DEPRESSIVE DISORDER NEC (61) HB-SS DISEASE W/CRISIS (1) OBS CHRONIC BRONCHITIS W/EXACERBATION (29) CHRONIC KIDNEY DISEASE (CKD) (14) CONGESTIVE HEART FAILURE, UNSPECIFIED (26) OTHER GENERAL SYMPTOMS (58) DIABETES W/O COMPLICATION, UNCONTROLLED (25) 0 100 200 300 400 500 600 700 800 900 1000 22 Count of Claims

Morphine Equianalgesic Dosage (MED) WA Medicaid Deaths Related to Prescription Opioids 2004-2006 250.00 3500 222.14 3137.419 3000 200.00 180.50 2420 187.11 2571.428 2500 Average MED 150.00 100.00 2000 1500 MED Average MED Per Day Per Client Max range of MED Per Client Per Month 1000 50.00 500 0.00 2004 2005 2006 0 23 Year

Behavioral Profile WA Medicaid Deaths Related to Prescription Opioids Alcohol/Drug Profile 2004-2006 21% (154 clients) had an at risk diagnosis Of those 154 clients, 70% had a diagnosis of drug poisoning 53% of clients had an event indicated need for alcohol/drug treatment 5% received a drug/alcohol assessment 12 months prior to death 22% received alcohol/drug treatment 12 months prior to death 24

Behavioral Profile WA Medicaid Deaths Related to Prescription Opioids 2004-2006 Mental Health Profile 39% of clients received mental health services in the 12 months prior to death #1 mental health diagnosis was depression 26% #1 medication used was an antidepressant 53% #2 medication used was an anticonvulsant (Clonazepam and Gabapentin) 39% 25

Top Therapeutic Class of Drugs WA Medicaid Deaths Related to Prescription Opioids 2004-2006 1. Analgesics, Narcotics 2. Anticonvulsants (Clonazepam and Gabapentin) 3. Selective Serotonin Reuptake Inhibitor (SSRIS) 4. Anti-anxiety Drugs 5. Muscle Relaxants 6. Gastric Acid Secretion Reducers 7. NSAIDS 8. Beta-Adrenergic Agents 9. Antipsychotic, Atypical 10. Penicillin 26

Children s Profile WA Medicaid Deaths Related to Prescription Opioids 2004-2006 Each child was from a dysfunctional family unit 93% came from a single parent household 20% were in several different foster homes 47% were raised by a relative other than parent 27% were homeless sometime in their life 67% had a parent or sibling with a mental disorder and substance abuse history or domestic violence or a criminal history 27

Children s Profile WA Medicaid Deaths Related to Prescription Opioids 2004-2006 100% of the children had a mental health disorder ranging from depression to high anxiety 40% were receiving 1 to 3 different mental health drugs, with 2 children receiving significantly higher than recommended dosage 73% had substance abuse issues, with 2 children at age 11 applied for assistance for substance abuse treatment 60% of the children had co-occurring diagnoses 28

Summary Profile of clients who inappropriately use healthcare services, have high ER visits and high narcotic use are same/similar group who are dying from prescription opioids The PRC program is just one tool which focus on the health and safety of clients to decrease inappropriate use of healthcare services. Complex issues requires more than one solution and the need for public and private partnerships. 29

Thank You Any Questions? Washington State PRC Team Website: http//maa.dshs.wa.gov/prr Phone: 1-360-725-1780 30